JG
STOK icon

Jain Global’s Stoke Therapeutics STOK Stock Holding History

Jain Global’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$356K Buy
+10,883
New +$349K ﹤0.01% 1314
2025
Q4 		– Sell
-24,340
Closed -$572K – 1502
2025
Q3 		$572K Buy
+24,340
New +$417K ﹤0.01% 721

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jain Global's STOK Position: Q2 2026 in Review

Jain Global opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 10,883 shares worth $356K. The stake represents ﹤0.01% of the portfolio and ranks #1314 among its holdings. This is a return to the name: Jain Global previously reported a position in STOK as recently as Q3 2025.

Jain Global first reported a position in STOK in Q3 2025 and has held it in 2 quarters since. The position peaked at $572K in Q3 2025. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Jain Global held 10,883 shares of Stoke Therapeutics worth $356K as of Q2 2026.
  • Stoke Therapeutics was a new Jain Global position in Q2 2026.
  • Stoke Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1314 holding.
  • Jain Global first reported a position in Stoke Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • Jain Global's Stoke Therapeutics position peaked at $572K in Q3 2025.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.